| Dr Osvaldo L Cardona, MD | |
|
Centro Plaza Professional Building, Carr 107 Km 2.4, Aguadilla, PR 00603 | |
| (939) 545-6601 | |
| (939) 545-6601 |
| Full Name | Dr Osvaldo L Cardona |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | Centro Plaza Professional Building, Aguadilla, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467454280 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 11919 (Puerto Rico) | Primary |
| Entity Name | Pr Renal Health And Research Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083923114 PECOS PAC ID: 9739377862 Enrollment ID: O20101216000155 |
News Archive
Later this month the United Nations will convene a high-level meeting on non-communicable diseases. The world's global health news has been so dominated by infectious culprits - HIV/AIDS, malaria, tuberculosis, influenza - that it's easy to forget just how big a toll conditions like diabetes, cancer and heart and lung disease take say experts.
Pregnant women exposed to passive smoking are more likely to have sleep disturbances such as subjective insufficient sleep, difficulty in initiating sleep, short sleep duration, and snoring loudly or breathing uncomfortably, according to a study published in the September 1 issue of the journal SLEEP.
Judith Villablanca, MD, of The Saban Research Institute of Children's Hospital Los Angeles, Susan Kreissman, MD, of Duke University Medical Center, and colleagues reported the results of a randomized, phase 3 clinical trial conducted by the Children's Oncology Group examining the effect of selectively removing (purging) tumor cells from blood stem cells before they are transplanted back into patients with high-risk neuroblastoma following high-dose chemotherapy.
Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Osvaldo L Cardona, MD Po Box 3768, San Sebastian, PR 00685-3768 Ph: (787) 299-0487 | Dr Osvaldo L Cardona, MD Centro Plaza Professional Building, Carr 107 Km 2.4, Aguadilla, PR 00603 Ph: (939) 545-6601 |
News Archive
Later this month the United Nations will convene a high-level meeting on non-communicable diseases. The world's global health news has been so dominated by infectious culprits - HIV/AIDS, malaria, tuberculosis, influenza - that it's easy to forget just how big a toll conditions like diabetes, cancer and heart and lung disease take say experts.
Pregnant women exposed to passive smoking are more likely to have sleep disturbances such as subjective insufficient sleep, difficulty in initiating sleep, short sleep duration, and snoring loudly or breathing uncomfortably, according to a study published in the September 1 issue of the journal SLEEP.
Judith Villablanca, MD, of The Saban Research Institute of Children's Hospital Los Angeles, Susan Kreissman, MD, of Duke University Medical Center, and colleagues reported the results of a randomized, phase 3 clinical trial conducted by the Children's Oncology Group examining the effect of selectively removing (purging) tumor cells from blood stem cells before they are transplanted back into patients with high-risk neuroblastoma following high-dose chemotherapy.
Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.
› Verified 3 days ago
Vivian Milagros Garza, Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: Hospital Buen Samaritano, 18 Ave Severiano Cuevas Km 141.1 Bo Caimital Bajo, Aguadilla, PR 00603 Phone: 787-658-0000 | |
Orlando Marini Roman, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Ave. Severiano Cuevas, Numero 18, Aguadilla, PR 00603 Phone: 787-819-1396 Fax: 787-819-1060 | |
Juan F Cancio, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2 Progreso St, Suite 204 Aguadilla Medical Building, Aguadilla, PR 00603 Phone: 787-891-1134 Fax: 787-891-1134 | |
Dr. Gilmar Gonzalez Romero, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Carretera 111 Km.2.4, Barrio Palmar, Aguadilla, PR 00603 Phone: 787-551-4051 Fax: 787-551-4052 | |
Yomarid Quinones, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 156 Calle Nicandro, Urb Garcia, Aguadilla, PR 00603 Phone: 787-754-0101 | |
Dr. Francisco Hiram Jaume Boscio, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Carr 110 Km 24.2 Edificio San Jose Suite 1, Bo Ceiba Baja, Aguadilla, PR 00604 Phone: 787-882-0434 Fax: 787-882-0449 | |
Dr. Hector J Colombany Lorenzo, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 111 St Km 2.5 Bo Palmar, Aguadilla, PR 00603 Phone: 787-877-2123 Fax: 787-877-2145 |